close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MEDIFAST INC Common Stock (NY:MED)

12.81 +0.08 (+0.63%)
Official Closing Price Updated: 7:00 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Medifast: 3 Key Takeaways for Long-Term Investors ↗
Cost cuts and a metabolic health pivot must prove they can reignite growth before cash reserves deplete. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
5 insightful analyst questions from Medifast’s Q3 earnings call
Medifast’s third quarter results were marked by a positive market response, as the company’s revenue slightly exceeded Wall Street’s expectations despite a s... 
Via StockStory
Topics Earnings
News headline image
Why Medifast (MED) stock is trading up today
What happened? Shares of wellness company Medifast (NYSE:MED) jumped 6.2% in the afternoon session after the company, in a press release, reported third quar... 
Via StockStory
Topics Artificial Intelligence
Medifast (NYSE:MED) Q3 2026 Earnings: Adjusted Loss Narrows as Revenue Meets Estimates ↗
Via Chartmill
News headline image
MED Q3 deep dive: new Trilogy brand and coach productivity drive evolving metabolic health strategy
Wellness company Medifast (NYSE:MED) reported Q3 2026 results topping the market’s revenue expectations, but sales fell by 19.4% year on year to $72.05 milli... 
Via StockStory
News headline image
Medifast (MED) Q3 2026 Earnings Call Transcript ↗
CEO Johnson targets Q4 profitability amid record coach productivity gains. 
Via The Motley Fool
Topics Earnings
News headline image
What Medifast (MED) Said on Its Q3 Earnings Call ↗
Medifast (NYSE:MED) reported third-quarter 2026 revenue of $72 million, down 19.4% from a year earlier, as the company continued to face a sharp decline in its active earning coach base. Management... 
Via MarketBeat
Topics Earnings
News headline image
Medifast (NYSE:MED) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations
Wellness company Medifast (NYSE:MED) reported Q3 2026 results beating Wall Street’s revenue expectations, but revenue fell by 19.4% year on year to $72.05 mi... 
Via StockStory
News headline image
Medifast (MED) Q3 earnings report preview: what to look for
Wellness company Medifast (NYSE:MED) will be announcing earnings results this Monday before market hours. Here’s what to look for. Medifast beat analysts’ re... 
Via StockStory
Topics Artificial Intelligence
News headline image
e.l.f. Beauty (NYSE:ELF) Q2 earnings: leading the personal care pack
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at e.l.f. Beauty (NYSE:ELF) and ... 
Via StockStory
Topics Economy
News headline image
1 Small-Cap Stock with Impressive Fundamentals and 2 Facing Challenges
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
Q2 Earnings Roundup: Medifast (NYSE:MED) And The Rest Of The Personal Care Segment
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Medifast (NYSE:MED) and its... 
Via StockStory
Topics Economy
News headline image
3 Cash-Producing Stocks That Concern Us
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
3 Unprofitable Stocks with Questionable Fundamentals
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv... 
Via StockStory
News headline image
3 Reasons to Sell MED and 1 Stock to Buy Instead
Medifast trades at $11.62 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time, the S&P 5... 
Via StockStory
Topics Stocks
News headline image
3 Small-Cap Stocks with Questionable Fundamentals
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Medifast (MED) Q2 2026 Earnings Call Transcript ↗
Coach count plummeted 48.7%, yet management targets profitability by Q4 2026. 
Via The Motley Fool
Topics Earnings
News headline image
Medifast’s Q2 Earnings Call: Our Top 5 Analyst Questions
Medifast’s second quarter was marked by stabilization in key business metrics despite continued pressure from declining coach numbers and shifting industry t... 
Via StockStory
Topics Earnings
News headline image
1 Stock Under $50 to Consider Right Now and 2 We Turn Down
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
Why Medifast (MED) Stock Is Trading Up Today
What Happened? Shares of wellness company Medifast (NYSE:MED) jumped 37.5% in the afternoon session after the company reported second-quarter results that su... 
Via StockStory
Topics Artificial Intelligence Economy Stocks
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Top movers in Tuesday's session ↗
Via Chartmill
News headline image
Medifast Q2 Earnings Call Highlights ↗
Medifast (NYSE:MED) reported second-quarter 2026 revenue of $76.4 million, down 27.6% from a year earlier, as its active earning coach base continued to decline amid the rapid adoption of GLP-1... 
Via MarketBeat
Topics Earnings
News headline image
Medifast (NYSE:MED) Beats Expectations in Strong Q2 CY2026, Stock Jumps 12.8%
Wellness company Medifast (NYSE:MED) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 27.6% year on year to $76.38 mil... 
Via StockStory
Topics Artificial Intelligence
News headline image
11 Consumer Staples Stocks Moving In Monday's After-Market Session ↗
Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market session. The market value of their outstanding shares is at $108.0 million. The company's, Q2 earnings came... 
Via Benzinga
News headline image
Earnings To Watch: Medifast (MED) Reports Q2 Results Tomorrow
Wellness company Medifast (NYSE:MED) will be reporting results this Monday after market hours. Here’s what you need to know. Medifast beat analysts’ revenue ... 
Via StockStory
News headline image
3 Out-of-Favor Stocks with Questionable Fundamentals
The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether... 
Via StockStory
News headline image
3 Unpopular Stocks That Concern Us
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
Topics Artificial Intelligence
News headline image
A Look Back at Personal Care Stocks’ Q1 Earnings: Medifast (NYSE:MED) Vs The Rest Of The Pack
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
Via StockStory
Topics Economy
News headline image
1 Cash-Heavy Stock to Target This Week and 2 Facing Headwinds
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.